Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGND) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities

2.4 / 5 stars · 57/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities

LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 0 shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-24.

Discontinued › Income Statement › Earnings Per Share

us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2021-02-24

  • LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2019-09-30 was 0.00 shares.
  • LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2019-06-30 was 0.00 shares, a 100.00% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2019-03-31 was 0.00 shares, a 100.00% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2018-09-30 was 0.00 shares, a 100.00% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2020 was 0.00 shares.
  • LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2019 was 0.00 shares, a 100.00% decline from fiscal 2018.
  • LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2018 was 693.00K shares, a 42.92% decline from fiscal 2017.
  • LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2017 was 1.21M shares.
Period endIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month as first filed
2020-12-310.00 shares
10-K · filed 2021-02-24
2019-12-310.00 shares
10-K · filed 2021-02-24
2019-09-300.00 shares
10-Q · filed 2019-11-08
0.00 shares
10-Q · filed 2019-11-08
2019-06-300.00 shares
10-Q · filed 2019-08-08
0.00 shares
10-Q · filed 2019-08-08
2019-03-310.00 shares
10-Q · filed 2019-05-09
2018-12-31693.00K shares
10-K · filed 2021-02-24
2018-09-300.00 shares
10-Q · filed 2019-11-08
924.00K shares
10-Q · filed 2019-11-08
923.65K shares
10-Q · filed 2018-11-08
2018-06-301.05M shares
10-Q · filed 2019-08-08
1.05M shares
10-Q · filed 2018-08-08
1.39M shares
10-Q · filed 2019-08-08
1.39M shares
10-Q · filed 2018-08-08
2018-03-311.72M shares
10-Q · filed 2019-05-09
1.72M shares
10-Q · filed 2018-05-09
2017-12-311.21M shares
10-K · filed 2020-02-27
2017-09-301.33M shares
10-Q · filed 2018-11-08
1.12M shares
10-Q · filed 2018-11-08
2017-06-301.08M shares
10-Q · filed 2018-08-08
1.01M shares
10-Q · filed 2018-08-08
2017-03-31941.31K shares
10-Q · filed 2018-05-09
2016-12-310.00 shares
10-K · filed 2019-02-28
2016-09-301.18M shares
10-Q · filed 2017-11-09
1.05M shares
10-Q · filed 2017-11-09
2016-06-300.00 shares
10-Q · filed 2017-08-09
0.00 shares
10-Q · filed 2017-08-09
977.34K shares
10-Q · filed 2016-08-04
2016-03-31749.74K shares
10-Q · filed 2017-05-09
2015-12-31499.00K shares
10-K · filed 2018-03-01
499.43K shares
10-K · filed 2016-02-26
2015-09-30745.59K shares
10-Q · filed 2016-11-14
402.94K shares
10-Q · filed 2016-11-14
2015-06-30463.23K shares
10-Q · filed 2016-11-14
231.62K shares
10-Q · filed 2016-11-14
2015-03-310.00 shares
10-Q · filed 2016-11-14
2014-12-310.00 shares
10-K · filed 2017-02-28
2014-09-300.00 shares
10-Q · filed 2015-11-09
0.00 shares
10-Q · filed 2015-11-09
2014-06-300.00 shares
10-Q · filed 2015-08-05
0.00 shares
10-Q · filed 2015-08-05